2025 first_quarter Filing
Q1Income
$70K
Filed
April 21, 2025
Lobbying Activities
Health IssuesView all
Issues related to cell and gene therapy and radioligand therapies Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutical products Implementation of the Inflation reduction Act Pharmaceutical innovation PBM policy issues HR 1672 The Maintaining Investments in New Innovations (MINI) Act Intellectual property Issues
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (8)
ZACHARY PFISTER
NADEAM ELSHAMI
ANDREW USYK
DAVID REID